More great client feedback
December 11, 2020 4:11 pm Leave your thoughtsWe’ve received some more positive feedback from one of our US pharma clients. Here’s what our client had to say:...
View Article
We’ve received some more positive feedback from one of our US pharma clients. Here’s what our client had to say:...
View Article
We were delighted to welcome some new recruits to the Hypha family this October. Chloe Herring and John Boyle join...
View Article
Hypha’s paper in ACS Medicinal Chemistry Letters on “Biotransformation: Impact and Application of Metabolism in Drug Discovery” was published in...
View Article
Check out a new white paper describing the joint efforts of Hypha and Galchimia, who together successfully synthesised metabolites of...
View Article
Hypha were honoured to be asked to contribute a chapter on “Metabolite Generation and Metabolite Characterization by NMR” in the...
View Article
This is an exciting opportunity for an intern to spend time on a research project to further exemplify the use...
View Article
Hypha are excited to announce they have relocated from Slough to Milton Park in Oxfordshire, one of the largest science...
View Article
Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant...
View Article
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the...
View Article
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response...
View Article